Waleed A. Hassen, MD, is a Staff Physician in the Surgical Subspecialties Institute at Cleveland Clinic Abu Dhabi.
He specializes in urologic oncology and minimally invasive and robotic surgery. Dr. Hassen is one of a handful of urologists worldwide who is formally trained in both urologic oncology and minimally invasive surgery.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Hassen was a faculty member of the James Buchanan Brady Urological Institute of the Johns Hopkins School of Medicine in Baltimore, Maryland, US. He also previously served as the Director of Urologic Oncology at the Mount Sinai School of Medicine in New York, New York, US.
Dr. Hassen has authored numerous research articles in leading peer-reviewed journals, as well as book chapters and videos. He is an editorial reviewer for numerous scientific journals and a member of several urological and oncologic societies, including the Society of Urologic Oncologists, the European Association of Urology, and Alpha Omega Alpha. He is currently the Chairperson of the National Comprehensive Cancer Network’s (NCCN) Middle East and North Africa Panel for the Modification of Prostate Cancer Guidelines. Dr. Hassen has lectured in and chaired numerous scientific meetings, and also serves as an international faculty member for the American Urological Association.
Dr. Hassen received his medical degree from Eastern Virginia Medical School in Norfolk, Virginia, US. He completed his residency in Urology at the Mount Sinai School of Medicine in New York, New York, US, and completed his fellowship in Urologic Oncology and Minimally Invasive and Robotic Surgery at Memorial Sloan Kettering Cancer Center, also in New York, New York, US.